Xerox has announced it is withdrawing its tender offer to acquire HP and will no longer seek to nominate a slate of candidates to HP’s board of directors.
CellFE, a company that is developing a microfluidics-based device for delivering gene-editing molecules, announced it raised $4.8 million in Series Seed funding.
Johnson & Johnson is ramping up its capacity for producing 1 billion doses of an experimental lead vaccine candidate for SARS-CoV-2 -- known as coronavirus.
Facebook is committing $100 million in grant money and promised ad spending for helping news outlets dealing with financial struggles due to the COVID-19 outbreak.
Gilead is expanding on its access to the experimental anti-coronavirus drug remdesivir in order to accelerate the emergency use for multiple severely ill patients.